ArticleCureus2026
Viscosity-Augmented Percutaneous Sclerotherapy for Recurrent Thoracic Spinal Aneurysmal Bone Cyst: A Technical Innovation to Mitigate Venous Washout.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 27-year-old male was operated on for a thoracic seven-vertebra aneurysmal bone cyst (ABC). On the six-year follow-up, he had radiological signs of recurrence. Treatment plan for recurrence was multiple sessions of percutaneous intralesional sclerotherapy with 3% of sodium tetradecyl sulphate (STS). The remarkable vascularity of the lesion resulted in rapid washout of the sclerosant mixture. Henceforth, an improvised technique was used in the third attempt. A thick sclerosant mixture injectate consisting of 3 ml of 3% STS mixed with 2 ml of gelatin sponge slurry (EG Gel 350-650 micron) and 2 ml of computed tomography (CT) contrast was used. At the six-month follow-up, there was new bone formation along the margins of the lytic lesion. The patient received two more sessions of the same injectate. At the two-year follow-up, the lesion showed no expansion of the lytic area with further increase in sclerosis. Modification of the injection technique with the use of a thick sclerosant mixture reduced the washout time. This case report describes the easy reproducibility of the technique and the simple logical problem-solving method, which is fundamental to Interventional radiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.